Dova Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 07, 2019 at 07:16 am EDT
Dova Pharmaceuticals, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was USD 4.001 million compared to USD 0 a year ago. Operating loss was USD 16.352 million compared to USD 13.677 million a year ago. Net loss was USD 16.379 million compared to USD 13.770 million a year ago. Basic loss per share was USD 0.58 compared to USD 0.52 a year ago.